當前位置:首頁 > 產品中心 > 生化試劑 > 分離材料及耗材類4 > Amberlite XAD4離子交換大孔吸附樹脂 37380-42-0

產品展示

Amberlite XAD4離子交換大孔吸附樹脂 37380-42-0

Amberlite XAD4離子交換大孔吸附樹脂 37380-42-0

型    號:
報    價: 12
分享到:

向日葵app下载安装免费為客戶提供產品信息,Amberlite XAD4離子交換大孔吸附樹脂 37380-42-0價格優惠,質量有保證。請您在交易過程中詳細確認,並向向日葵app下载安装安卓污浪浪视频銷售人員確認購買方式,谘詢!

Amberlite XAD4離子交換大孔吸附樹脂 37380-42-0 詳細資料

公司專業銷售生化試劑,氨基酸類,酶類,蛋白質類,植物激素及核酸類,碳水化合物類,色素類,緩衝劑類,培養基類,涉及到分析科學,生命科學,高端化學,材料科學。了解更多產品!
Amberlite XAD4離子交換大孔吸附樹脂 37380-42-0Amberlite XAD4離子交換大孔吸附樹脂/Amberlite XAD4    BR,20-60目    100克    ,Sigma-Aldrich、Amresco、Amersham、Serva、AppliChem等品牌,    37380-42-0    RT
500克    ,Sigma-Aldrich、Amresco、Amersham、Serva、AppliChem等品牌,

產品名稱Amberlite XAD4離子交換大孔吸附樹脂 37380-42-0
英文名稱37380-42-0
規格可接受大包訂製

中文名稱:     
英文名稱: 37380-42-0    
產品規格: BR,20-60目     
包裝:500毫升     
CAS號:37380-42-0    
級別:BR    
Autoignition temp:800 °F    
Matrix:styrene-divinylbenzene    
Particle size :20~60 mesh    
Pore size:~0.98mL/g pore volume;40 Å mean pore size    
Surface area:725 m2/g    
Density:1.02 g/mL at 25℃(true wet);1.08 g/mL at 25℃(skeletal)    
性狀:玻璃粉,大孔酚醛係吸附樹脂。易於吸附大分子量的水溶性有機物    
用途:生化研究。吸附樹脂用於去除蛋白、高分子量著色劑、有機雜質。用於純化藥物方麵的具體應用如下:氨基酸和生物堿類物質的脫色、蛋白質去苦味、酶載體;提取蛋白質、多肽和動植物有效成份;水解:脫色、除去蛋白質、雜質離子,糠醛等會影響口味的離子;有機酸:脫色(發酵法生產有機酸,如檸檬酸、乳酸)    
保存:RT
是我司的優勢產品,在行業中獲得許多客戶的讚譽。平易的價格,讓您補足實驗“糧響”。我司專業供應科研實驗試劑,保質保量。嚴格生產操作,技術成熟。科研博大精深,學科之間相互滲透,向日葵app下载安装免费以滿足客戶需求為己任,力求全麵服務於新老客戶。

aminoethyl]-benzenemethanol
L-Norpseudoephedrine (5 mg)    (-)-Norpseudoephedrine; (αR)-α-[(1R)-1-aminoethyl]-benzenemethanol
L-Norpseudoephedrine (50 mg)    (-)-Norpseudoephedrine; (αR)-α-[(1R)-1-aminoethyl]-benzenemethanol
Alprenolol (hydrochloride) (100 mg)    H 56/28; 1-[(1-methylethyl)amino]-3-[2-(2-propen-1-yl)phenoxy]-2-propanol, monohydrochloride
Alprenolol (hydrochloride) (25 mg)    H 56/28; 1-[(1-methylethyl)amino]-3-[2-(2-propen-1-yl)phenoxy]-2-propanol, monohydrochloride
Alprenolol (hydrochloride) (250 mg)    H 56/28; 1-[(1-methylethyl)amino]-3-[2-(2-propen-1-yl)phenoxy]-2-propanol, monohydrochloride
Alprenolol (hydrochloride) (50 mg)    H 56/28; 1-[(1-methylethyl)amino]-3-[2-(2-propen-1-yl)phenoxy]-2-propanol, monohydrochloride
Metolazone (10 mg)    SR 720-22|Zaroxolyn; 7-chloro-1,2,3,4-tetrahydro-2-methyl-3-(2-methylphenyl)-4-oxo-6-quinazolinesulfonamide
Metolazone (100 mg)    SR 720-22|Zaroxolyn; 7-chloro-1,2,3,4-tetrahydro-2-methyl-3-(2-methylphenyl)-4-oxo-6-quinazolinesulfonamide
Metolazone (25 mg)    SR 720-22|Zaroxolyn; 7-chloro-1,2,3,4-tetrahydro-2-methyl-3-(2-methylphenyl)-4-oxo-6-quinazolinesulfonamide
Metolazone (50 mg)    SR 720-22|Zaroxolyn; 7-chloro-1,2,3,4-tetrahydro-2-methyl-3-(2-methylphenyl)-4-oxo-6-quinazolinesulfonamide
7-methyl Guanosine (100 mg)    7-
7-methyl Guanosine (25 mg)    7-
7-methyl Guanosine (250 mg)    7-
7-methyl Guanosine (50 mg)    7-
Lofexidine (hydrochloride) (1 g)    2-[1-(2,6-dichlorophenoxy)ethyl]-4,5-dihydro-1H-imidazole, monohydrochlorideSR 1555 (hydrochloride) (5 mg)    1-(4-((4’-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)-[1,1’-biphenyl]-4-yl)methyl)piperazin-1-yl)ethanone, monohydrochloride; SR 1555 (hydrochloride)
SR 3335 (1 mg)    N-[4-[2,2,2-trifluoro-1-hydroxy-1-(trifluoromethyl)ethyl]phenyl]-2-thiophenesulfonamide; ML 176; SR 3335
SR 3335 (10 mg)    N-[4-[2,2,2-trifluoro-1-hydroxy-1-(trifluoromethyl)ethyl]phenyl]-2-thiophenesulfonamide; ML 176; SR 3335
SR 3335 (25 mg)    N-[4-[2,2,2-trifluoro-1-hydroxy-1-(trifluoromethyl)ethyl]phenyl]-2-thiophenesulfonamide; ML 176; SR 3335
SR 3335 (5 mg)    N-[4-[2,2,2-trifluoro-1-hydroxy-1-(trifluoromethyl)ethyl]phenyl]-2-thiophenesulfonamide; ML 176; SR 3335
Canertinib (hydrochloride) (10 mg)    N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[3-(4-morpholinyl)propoxy]-6-quinazolinyl]-2-propenamide, dihydrochloride; CI 1033|PD 183805; Canertinib (hydrochloride)
Canertinib (hydrochloride) (25 mg)    N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[3-(4-morpholinyl)propoxy]-6-quinazolinyl]-2-propenamide, dihydrochloride; CI 1033|PD 183805; Canertinib (hydrochloride)
Canertinib (hydrochloride) (5 mg)    N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[3-(4-morpholinyl)propoxy]-6-quinazolinyl]-2-propenamide, dihydrochloride; CI 1033|PD 183805; Canertinib (hydrochloride)
Canertinib (hydrochloride) (50 mg)    N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[3-(4-morpholinyl)propoxy]-6-quinazolinyl]-2-propenamide, dihydrochloride; CI 1033|PD 183805; Canertinib (hydrochloride)
1-hydroxy Vitamin D2 (1 mg)    4-methylene-5Z-[2E-[(1R,3aS)-octahydro-7aR-methyl-1R-[1R,4,5-trimethyl-2E-hexen-1-yl]-4H-inden-4-ylidene]ethylidene]-1,3S-cyclohexanediol; 1-Hydroxyergocalciferol|Hectorol|TSA 840|Doxercalciferol; 1-hydroxy Vitamin D2

產品相關關鍵字: Amberlite XAD4離子交換大孔吸附樹脂 37380-42-0 37380-42-0
Amberlite XAD4離子交換大孔吸附樹脂 37380-42-0 詢價留言

留言框

  • 產品:

  • 留言內容:

  • 您的單位:

  • 您的姓名:

  • 聯係電話:

  • 常用郵箱:

  • 詳細地址:

  • 省份:

  • 驗證碼:

    請輸入計算結果(填寫阿拉伯數字),如:三加四=7
上一篇 : 大孔吸附樹脂D1019060-05-3    下一篇 :  離子交換大孔吸附樹脂

上海向日葵app下载安装免费版生物科技有限公司專業提供Amberlite XAD4離子交換大孔吸附樹脂 37380-42-0等產品信息,歡迎來電谘詢! GoogleSitemap   備案號:滬ICP備12048703號-8
©2021上海向日葵app下载安装免费生物科技有限公司 版權所有 總訪問量:141959 Design By 環保在線 

聯係人: 馬先生
電話:
021-39921927,021-39596320
手機:
15026555973
點擊這裏給我發消息
點擊這裏給我發消息